59 results on '"Forman, S."'
Search Results
2. LB1702 Lebrikizumab does not impact vaccine-induced immune responses: Results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis
3. PO-1171 Ten-year follow-up of tandem autologous transplantation with total marrow irradiation for myeloma
4. 208 Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies
5. Lung, Renal, Thyroid and Cataract Toxicities after Myeloablative Total Marrow Irradiation (TMI) in Patients Undergoing Hematopoietic Cell Transplantation (HCT)
6. 554 The Janus kinase 1 (JAK1) inhibitor PF-04965842 reduces signs and symptoms of moderate to severe atopic dermatitis (AD)
7. Therapy-Related Myelodysplasia: Somatic Mutations and Allogeneic Hematopoietic Cell Transplantation Outcomes
8. ZUMA-2: A phase 2 multi-center study evaluating the efficacy of KTE-C19 (Anti-CD19 CAR T cells) in patients with relapsed/refractory Mantle cell lymphoma (R/R MCL)
9. Évaluation de la stratégie posologique optimale à moyen terme pour l’utilisation de l’adalimumab dans l’hidrosadénite suppurée modérée à sévère ; résultats intégrés des études de phase 3, randomisées, contrôlées contre placebo PIONEER I & II
10. Phase 1 Dose Escalation Trial of Total Marrow and Lymphoid Irradiation (TMLI) Using Helical Tomotherapy Combined With Etoposide (VP16) and Cyclophosphamide (CY) in Patients With Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT)
11. Extramedullary (EM) Relapse Following Total Marrow and Lymphoid Irradiation (TMLI) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)
12. Long-Term Survival after High-Dose Chemotherapy Followed by Peripheral Stem Cell Rescue for High-Risk, Locally Advanced/Inflammatory, and Metastatic Breast Cancer
13. Cyclophosphamide Priming with Intravenous Plerixafor and GCSF Mobilization for Multiple Myeloma
14. Is Kir Haplotype Matching Important?
15. Cord Blood Transplantation for Long Term Management or Possible Cure of HIV Infection
16. Phase I Dose Escalation Trials of Total Marrow Irradiation (TMI) using Helical TomoTherapy (HT) with Concurrent Full-intensity Chemotherapy in Patients with Advanced Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)
17. Sirolimus, Tacrolimus, and rabbit ATG (r-ATG) as Graft-Versus-Host Disease Prophylaxis in Patients Undergoing Unrelated Donor Peripheral Blood Hematopoietic Cell Transplant (HCT): Extended Follow Up and Updated Analysis
18. Influence of Genomic Structural Variants on GVHD and Relapse Risk in Lymphoma Patients Treated With Allogeneic HSCT
19. Phase I Trial of Escalated Doses of Targeted Marrow Radiation Delivered By Tomotherapy Combined With Etoposide and Cyclophosphamide; an Allogeneic HCT Preparative Regimen for Patients With Advanced Leukemia
20. Predictors of Therapy-Related Myelodysplasia and Acute Myeloid Leukemia (t-MDS/AML) After Autologous Hematopoietic Cell Transplantation (AHCT) for Hematologic Malignancies
21. Elevated Pre Transplant Serum Ferritin is Associated With Increased Risk of Invasive Mold Infection (IMI) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
22. 247 Dual function BAFF receptor aptamers inhibit ligand induced proliferation and deliver siRNAs to NHL cells
23. Denials Of Treatment Coverage By Health Insurance Carriers Restrict Patient Recruitment On A Randomized Clinical Trial: Experience Of 95 Patients With Systemic Sclerosis (SSc) Enrolled In The SCOT (Scleroderma: Cyclophosphamide Or Transplantation) Trial
24. Sirolimus, Tacrolimus, And Rabbit ATG (rATG) As Graft-Versus-Host Prophylaxis In Patients Undergoing Unrelated Donor Hematopoietic Stem Cell Transplant (HCT)
25. Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning As Treatment For Mature T-Cell Lymphomas
26. Is Low Dose Cyclophosphamide Plus G-CSF Moblization As Effective As Mozobil (Plerixafor) Plus G-CSF In Multiple Myeloma (MM) Patients Eligible For Tandem Transplant?
27. Severe Transplant Associated Microangiopathy (TAM) May Be Linked to Severe Organ Injury in Pediatric Patients Treated with Sirolimus (SIR) and Calcineurin Inhibitor (CNI) for Prevention or Treatment of Graft-Vs-Host Disease (GVHD)
28. A188 Total Marrow Irradiation (TMI) as Part of Tandem Autotransplantation (TAT) for Multiple Myeloma
29. Total Marrow and Lymph Node Irradiation (TMLI) with Fludarabine (FLU) and Melphalan (MEL) Is Well Tolerated and May Result in Improved Outcome in Patients (PTS) with Advanced Hematological Malignancies
30. 329: Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia (SAA) using a Non-Myeloablative Conditioning Regimen (NMCR)
31. 23: A Novel Method to Reduce Rates of Extensive Chronic GvHD (cGvHD) without Increased Relapse for Cord Blood Transplant
32. 293: Allogeneic Hematopoietic Cell Transplantation (HCT) in Chemotherapy Refractory Chronic Lymphocytic Leukemia (CLL)
33. 317: Impact of Prophylactic Red Blood Cell Exchange for Prevention of Severe Immune Hemolysis in Pediatric Minor ABO-Mismatched Allogeneic Peripheral Blood Progenitor Cell Transplantation
34. 131: Both KIR and Its Ligand Play a Role in Hematopoietic Stem Cell Transplants (HCT)
35. 153: A Retrospective Audited Analysis of 107 Adult Patients with Malignancies Transplanted with Unrelated Plasma Depleted Cord Blood (PD CB)
36. 70: Improved Outcome for Transplantation of Pediatric Patients with Non-Malignant Disorders with Unwashed Plasma Depleted Cord Blood (PD CB)
37. 378: Tacrolimus, Sirolimus and Antithymocyte Globulin (rATG) for Graft Versus Host Disease Prophylaxis for Unrelated Donor Hematopoietic Cell Transplantation
38. 324: The Feasibility of using CCR5Δ32/Δ32 Hematopoietic Stem Cell Transplants for Immune Reconstitution in HIV-Infected Children
39. Reduced Acute Toxicities With Image Guided Targeted Marrow Irradiation (TMI) Using Helical TomoTherapy (HT) in Patients With Multiple Myeloma and Acute Leukemia Undergoing Hematopoietic Cell Transplantation (HCT)
40. 363: Adult patients with malignancies transplanted with plasma depleted cord blood (PD CB) – a retrospective audited analysis of 68 patients
41. 100: Hematopoietic stem cell transplantation with autologous cord blood units in two patients with severe aplastic anemia
42. 52: Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation (HCT)
43. 369: Reduced-intensity stem cell transplantation for high-risk acute lymphoblastic leukemia
44. 263: Non-myeloablative conditioning therapy with fludarabine, cyclophosphamide and ATG allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donor in patients with severe aplasic anemia (SAA)
45. 21: Total marrow irradiation (TMI) using helical tomotherapy
46. 267: Reduced risk of relapse in pediatric patients after double unit cord blood transplantation? A single institution experience
47. 13: Unrelated cord blood transplantation (UCBT) for 59 pediatric patients with benign indications using plasma depleted cord blood (PD CB) – an audited retrospective analysis
48. 2530
49. Unexpected results from the application of signature-tagged mutagenesis to identify Yersinia pestis genes required for adherence and invasion
50. P-44 Longitudinal assessment ofhematopoietic abnormalities following autologous hematopoietic cell transplantation for lymphoma and association with risk of therapy-related myelodysplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.